Detection of aberrant methylation of RASSF1A gene in the tissue and the serum from ovarian tumor patients and its clinical significance

Chinese Journal of Cancer Prevention and Treatment

Volumn 15, Issue 5, 2008, Pages 374-377

  Li, Qi Rong ^a   Liu, Pei Shu ^a   Feng, Jin Bo ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Genes, ras; Methylation; Ovarian neoplasms genetics; Polymerase chain reaction

Indexed keywords

EID: 84859227811     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Vergote I, DeBrabante J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage 1 invasive epithelial ovarian carcinoma[J]. Lancet, 2001, 357(9251): 176-182.
2. Yang H J, Liu V W, Wang Y, et al. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients[J]. Gynecol Oncol, 2004, 93(2): 435-440.
3. Grady W M, Rajput A, Lutterbaugh J D, et al. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer[J]. Cancer Res, 2001, 61(3): 900-902.
4. Herman J G, Graff R, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG island[J]. Proc Natl Acad Sci USA, 1996, 93(18): 9821-9826.
5. Dammann R, Li C, Yoon J H, et al. Epigenetic of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3[J]. Natgenet, 2000, 25(3): 315-319.
6. Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis[J]. Proc Natl Acad Sci USA, 2001, 98(13): 7504-7509.
7. Vos M D, Ellis C A, Bell A, et al. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis[J]. J Biol Chem, 2000, 275(46): 35669-35672.
8. Yu M Y, Tong J H M, Chan P K S, et al. Ilypermethylation of the tumor suppressor gene RASSF1A and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers[J]. Int J Cancer, 2003, 105(2): 204-208.
9. 2006, 27(17): 1577-1579.
10. Fischer J R, Ohnmacht U, Rieger N, et al. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma[J]. Lung Cancer, 2006, 54(1): 109-116.
11. Jo H, Kim J W, Kang G H, et al. Association of promoter hypermethylation of the RASSF1A gene with prognostic parameters in endometrial cancer[J]. Oncol Res, 2006, 16(4): 205-209.